Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mu-type opioid receptor | ||
Ligand | BDBM50140746 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_148227 | ||
Ki | 435±n/a nM | ||
Citation | Chen, Z; Goehring, RR; Valenzano, KJ; Kyle, DJ Design and synthesis of novel small molecule N/OFQ receptor antagonists. Bioorg Med Chem Lett14:1347-51 (2004) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mu-type opioid receptor | |||
Name: | Mu-type opioid receptor | ||
Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44789.51 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P35372 | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM50140746 | |||
n/a | |||
Name | BDBM50140746 | ||
Synonyms: | (3aR,7aR)-1-[1-(4-Propyl-cyclohexyl)-piperidin-4-yl]-octahydro-benzoimidazol-2-one | CHEMBL26681 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H37N3O | ||
Mol. Mass. | 347.538 | ||
SMILES | CCCC1CCC(CC1)N1CCC(CC1)N1[C@@H]2CCCC[C@H]2NC1=O |wU:21.24,wD:16.17,(-1.19,-11.31,;-1.6,-9.82,;-.53,-8.73,;-.93,-7.25,;.15,-6.15,;-.27,-4.65,;-1.77,-4.28,;-2.85,-5.38,;-2.43,-6.87,;-2.19,-2.79,;-3.67,-2.39,;-4.08,-.93,;-3,.16,;-1.53,-.22,;-1.11,-1.71,;-3.41,1.64,;-4.86,2.12,;-6.19,1.35,;-7.53,2.12,;-7.53,3.65,;-6.19,4.42,;-4.86,3.65,;-3.41,4.13,;-2.5,2.88,;-.97,2.88,)| | ||
Structure |